Mode
Text Size
Log in / Sign up

Patient Questions

Real questions from health communities, answered with cited research from PubMed and Vellito's article corpus. Plain language, no medical advice. How this works.

Oncology

Can immune-checkpoint inhibitors cause thyroid dysfunction in lung cancer patients?

Yes. In lung cancer patients, immune-checkpoint inhibitors commonly cause thyroid problems, mostly mild hypothyroidism, affecting about 16% in one study and raising risk…

Oncology

How do KRAS mutations affect the tumor microenvironment in pancreatic adenocarcinoma?

KRAS mutations, found in most pancreatic adenocarcinomas, help build an immunosuppressive tumor microenvironment that blocks immune attack and resists therapy [2][5][6].

Oncology

What are the optimization strategies for CAR T-cell therapy in immune-mediated diseases?

Optimization of CAR T-cell therapy for immune-mediated diseases focuses on improving safety, precision, and durability through genetic engineering, metabolic reprogramming, and…

Oncology

What is the response rate for intrathecal chemotherapy in lung cancer leptomeningeal metastasis?

Across studies, intrathecal chemotherapy for lung cancer leptomeningeal metastasis produces objective response rates of roughly 34.5% to 86.4%, with higher rates in some…

Oncology

Can intrathecal therapy improve neurological outcomes for leptomeningeal metastasis?

Intrathecal therapy can shrink tumors and ease neurological symptoms in some patients with leptomeningeal metastasis, but benefits vary widely and it is not a cure.

Oncology

Can pancreatic cancer patients with leptomeningeal metastasis survive for a long time?

Leptomeningeal metastasis from pancreatic cancer is rare and usually has a very short median survival of 1 to 2 months, but rare individual cases have lived longer with intensive…

Oncology

Does using an Ommaya reservoir for intrathecal chemotherapy help leptomeningeal metastasis?

Intrathecal chemotherapy through an Ommaya reservoir is a standard way to treat leptomeningeal metastasis, and comparative evidence suggests it may improve disease control and…

Oncology

How is EGFR-mutant lung cancer treated when it causes leptomeningeal metastasis?

For EGFR-mutant lung cancer that has spread to the lining of the brain (leptomeningeal metastasis), studies point to osimertinib, sometimes combined with bevacizumab, and…

Oncology

Does intrathecal chemotherapy improve survival for patients with leptomeningeal metastasis?

Intrathecal chemotherapy can shrink or stabilize leptomeningeal metastasis and may extend survival in some patients, but benefit varies by cancer type and the evidence is not…

Oncology

Is capecitabine an option for women with HER2-positive breast cancer?

Yes. Capecitabine is used in HER2-positive breast cancer, most often combined with anti-HER2 drugs, and it has shown benefit in metastatic disease, including brain metastases…

Oncology

Is retifanlimab used as a first-line treatment for Merkel Cell Carcinoma?

Retifanlimab is approved as a treatment for metastatic or recurrent locally advanced Merkel cell carcinoma, but it is not the standard first-line treatment for non-metastatic…

Oncology

Are there links between paraganglioma and thyroid cancer lymph node spread?

Some inherited gene mutations can raise the risk of both paraganglioma and thyroid cancer, but the sources do not show that paraganglioma directly causes thyroid cancer lymph…

Oncology

What is the risk of metastasis for patients with the SDHD mutation and paraganglioma?

For people with an SDHD mutation who develop paraganglioma, the risk of metastasis appears to be low, around 4% in one meta-analysis, much lower than for SDHB mutations [6].

Oncology

What is the prevalence of CLDN18.2 expression in gastric adenocarcinoma patients?

CLDN18.2 is found in roughly 30% to 34% of gastric adenocarcinoma patients when using the stricter clinical cutoff, though rates vary by threshold and population [4][6].

Oncology

Does combining chemotherapy and immune checkpoint inhibitors improve response in gastric adenocarcinoma?

Yes. Adding immune checkpoint inhibitors to chemotherapy improves pathological response rates in gastric adenocarcinoma, though the survival benefit is less consistent.

Oncology

Can fluorescence-guided imaging be used to find neoplasms in veterinary medicine?

Yes. Fluorescence-guided imaging is already used in veterinary surgical oncology to help find and remove tumors, though it is not perfect and can miss or falsely flag tissue…

Oncology

How does the CXCL16/CXCR6 axis affect the growth of neoplasms?

The CXCL16/CXCR6 axis acts as a "double-edged sword" in cancer, where it can either promote tumor growth and drug resistance or be targeted to inhibit tumor progression.

Oncology

Can the drugs pazopanib and axitinib cause cholecystitis in cancer patients?

A single case report links pazopanib and axitinib to probable cholecystitis in a kidney cancer patient, but this is rare and based on limited evidence [1].

Oncology

Can molecular markers improve over traditional grading for oral potentially malignant disorders?

Molecular markers may improve risk assessment for oral potentially malignant disorders (OPMD) because traditional grading based on tissue appearance can be unreliable due to the…

Oncology

Are molecular markers better for assessing risk in oral potentially malignant disorders?

Molecular markers show promise for improving risk assessment in oral potentially malignant disorders, but they are not yet proven better than standard histopathology and need…

Oncology

What are the outcomes for patients with relapsed Wilms tumor in the UK?

A UK trial for relapsed Wilms tumor reported a 63% four-year event-free survival rate and a 68% overall survival rate.

Oncology

Can an epithelial-type Wilms tumor be treated with surgery?

Surgery is a standard treatment for epithelial-type Wilms tumor in both children and adults.

Oncology

Can a Wilms tumor occur in an adult woman?

While Wilms tumor is primarily a childhood cancer, it can occur in adult women, though these cases are extremely rare.

Oncology

Can a Wilms tumor return many years after the initial diagnosis?

While rare, Wilms tumor can recur many years after the initial diagnosis, with one documented case occurring 32 years after the first diagnosis.

How this works

We pull real patient questions from public Reddit health communities (r/AskDocs, r/diabetes, r/menopause, etc.). Each question is rewritten into a generic medical question (no personal details), then answered by an AI using only cited sources from Vellito's article database and PubMed. A second AI independently scores each answer for accuracy and citation fidelity before publication. Answers below the safety threshold or touching emergency, dosing, or pediatric topics are queued for human review and never auto-published.

This is not medical advice. Always speak with your own doctor before making decisions about your health.